Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2720]
News [7060]
Articles [271]
Editorials [8]
Conferences [215]
elearning [41]
ESMO 2017: Combination immunotherapy in second/third line extends mesothelioma survival to 15 months
ESMO 2017: Combination immunotherapy in second/third line extends mesothelioma survival to 15 months
ESMO 2017: Cancer patients struggle with key aspects of clinical trials
ESMO 2017: Cancer patients struggle with key aspects of clinical trials
ESMO 2017: Taselisib boosts breast tumour shrinkage in LORELEI trial
ESMO 2017: Taselisib boosts breast tumour shrinkage in LORELEI trial
Genetic alterations that make a type of brain cancer more aggressive were identified
Genetic alterations that make a type of brain cancer more aggressive were identified
Some stroke survivors may have underlying cancer
Some stroke survivors may have underlying cancer
ESMO 2017: Patients with high risk prostate cancer may benefit “equally” from two new treatments
ESMO 2017: Patients with high risk prostate cancer may benefit “equally” from two new treatments
The STING of death in T cells
The STING of death in T cells
Recurrence of prostate cancer could be reduced thanks to exciting new discovery
Recurrence of prostate cancer could be reduced thanks to exciting new discovery
Vaccine to prevent most cervical cancers shows long-term effectiveness
Vaccine to prevent most cervical cancers shows long-term effectiveness
ESMO 2017: ALEX and ALUR trials of alectinib show CNS benefit in NSCLC
ESMO 2017: ALEX and ALUR trials of alectinib show CNS benefit in NSCLC

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation